11,024
Views
36
CrossRef citations to date
0
Altmetric
Supplement: introducing oral semaglutide and the PIONEER program to primary care

GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date

&
Pages 3-14 | Received 01 Jun 2020, Accepted 16 Jul 2020, Published online: 08 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.